CCG
EW icon

Cypress Capital Group’s Edwards Lifesciences EW Stock Holding History

Cypress Capital Group’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-3,536
Closed -$296K – 283
2021
Q1 		$296K Sell
3,536
-203
-5% -$17.2K 0.04% 237
2020
Q4 		$341K Sell
3,739
-371
-9% -$30.8K 0.05% 231
2020
Q3 		$328K Sell
4,110
-444
-10% -$34.6K 0.05% 210
2020
Q2 		$315K Buy
+4,554
New +$324K 0.06% 205
2016
Q3 		– Sell
-20,655
Closed -$687K – 183
2016
Q2 		$687K Sell
20,655
-3,987
-16% -$136K 0.16% 106
2016
Q1 		$725K Buy
24,642
+3,474
+16% +$95.9K 0.18% 101
2015
Q4 		$557K Sell
21,168
-9,900
-32% -$257K 0.13% 119
2015
Q3 		$736K Buy
31,068
+294
+1% +$7.1K 0.18% 101
2015
Q2 		$731K Hold
30,774
– – 0.17% 111
2015
Q1 		$731K Buy
30,774
+4,584
+18% +$103K 0.17% 110
2014
Q4 		$556K Buy
26,190
+8,112
+45% +$163K 0.13% 127
2014
Q3 		$308K Buy
+18,078
New +$285K 0.07% 172

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Cypress Capital Group's EW Position: Q2 2021 in Review

Cypress Capital Group sold out of Edwards Lifesciences (EW) in Q2 2021, closing a stake of 3,536 shares — an estimated $296K sold.

Cypress Capital Group first reported a position in EW in Q3 2014 and held it in 12 quarters. The position peaked at $736K in Q3 2015. 1,188 funds tracked by Wall St. Rank hold EW as of Q2 2021.

  • Cypress Capital Group reported no remaining Edwards Lifesciences position as of Q2 2021 after selling out during the quarter.
  • Cypress Capital Group sold 3,536 Edwards Lifesciences shares in Q2 2021, an estimated $296K.
  • Cypress Capital Group first reported a position in Edwards Lifesciences in Q3 2014 and held it in 12 quarters.
  • Cypress Capital Group's Edwards Lifesciences position peaked at $736K in Q3 2015.
  • 1,188 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2021.

Based on Cypress Capital Group's 13F filing for Q2 2021, filed 13 Jul 2021.